bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
- RxCUI
- 1012377
- RxNorm name
- bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
- Display name
- BUPivacaine/EPINEPHrine (Injectable)
- Full name
- bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
- Term type
- SCD
- Status
- Active
- Strength
- 2.5-0.005 mg/ml
- Dose form
- Sol
- Route
- Injectable
- Updated
- 2026-10-27 17:46:04
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bupivacaine hydrochloride | 2.5 MG / 1 ML | bupivacaine | bupivacaine hydrochloride |
| epinephrine bitartrate | 5 MCG / 1 ML | epinephrine | epinephrine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Solution | 316949 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bupivacaine | 1815 |
| epinephrine | 3992 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | BUPivacaine hydrochloride 2.5 MG/ML / EPINEPHrine 0.005 MG/ML Injectable Solution | 1 | NAMES |
| RxNorm Name | bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution | 1 | NAMES |
| RxNorm Synonym | bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1012377 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-9043-01 | 0409-9043 | Bupivacaine Hydrochloride and Epinephrine BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | ANDA071167 |
| 51662-1397-1 | 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA070967 |
| 51662-1397-2 | 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA070967 |
| 51662-1397-3 | 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | ANDA070967 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA071167 | 0409-9043 | Bupivacaine Hydrochloride and Epinephrine BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | ANDA | Hospira, Inc. |
| ANDA070967 | 51662-1397 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | ANDA | HF Acquisition Co LLC, DBA HealthFirst |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 00409174630 00409174610 00409175250 1012377 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 0409-9043-01 0409-9043 00409904217 00409904301 00409904211 00409904311 00409904216 00409904201 1012377 |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 1012377 |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 51662-1397-2 51662-1397-3 51662-1397-1 51662-1397 51662139703 51662139702 51662139701 1012377 |
| SENSORCAINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb | 2023-04-30 | Boxed warning, Warnings, Adverse reactions | 1012377 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 02a845c3-4521-4926-e397-25ab536e7cf6 | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 39 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, for infiltration, perineural, caudal, or ep | 20260309 |
| 67578b56-7540-487e-1fba-481255620e78 | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 38 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20260529 |
| bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 7 | These highlights do not include all the information needed to use SENSORCAINE ® -MPF, SENSORCAINE ® -MPF WITH EPINEPHRINE, SENSORCAINE ® , and SENSORCAINE ® WITH EPINEPHRINE, safely and effectively. See full prescribing information for SENSORCAINE ® -MPF, SENSORCAINE ® -MPF WITH EPINEPHRINE, SENSORCAINE ® , and SENSORCAINE ® WITH EPINEPHRINE. SENSORCAINE ® -MPF (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use SENSORCAINE ® -MPF WITH EPINEPHRINE (bupiv | 20230430 |
| a1a96ebb-31f2-43d5-8dd9-b0cc0d9cbd50 | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 5 | 0.25% Bupivacaine HCL and Epinephrine 1:200,000 Injection, USP 30 mL Single Dose Vial | 20251027 |
| 93cf0914-de08-4ec6-8f8c-d663243b9958 | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 5 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | 20240202 |
| 946ce625-3647-5083-e053-2a95a90a1ebc | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 4 | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE INJECTION, USP) WITH EPINEPHRINE 1:200,000 (AS BITARTRATE) 0.25% 125mg per 50mL (2.5mg per mL) 50mL VIAL | 20240130 |
| 6a60cb55-530a-41ee-bc78-971eaf9f0850 | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution [PSN] · bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [SCD] · bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution [SY] | 3 | 4 | 20120307 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261023 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261014 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260529 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260423 |
| 02a845c3-4521-4926-e397-25ab536e7cf6 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, for infiltration, perineural, caudal, or ep | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260309 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20251106 |
| a1a96ebb-31f2-43d5-8dd9-b0cc0d9cbd50 | 0.25% Bupivacaine HCL and Epinephrine 1:200,000 Injection, USP 30 mL Single Dose Vial | Henry Schein, Inc. | 20251027 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250828 |
| 67578b56-7540-487e-1fba-481255620e78 | These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 1972 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20250825 |
| a1a96ebb-31f2-43d5-8dd9-b0cc0d9cbd50 | 0.25% Bupivacaine HCL and Epinephrine 1:200,000 Injection, USP 30 mL Single Dose Vial | Henry Schein, Inc. | 20241014 |
| 946ce625-3647-5083-e053-2a95a90a1ebc | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE INJECTION, USP) WITH EPINEPHRINE 1:200,000 (AS BITARTRATE) 0.25% 125mg per 50mL (2.5mg per mL) 50mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20240130 |
| fab28f67-9dfa-4bf7-8758-c0c4b6aef56a | 0.25% Bupivacaine HCL and Epinephrine 1:200,000 Injection, USP 30 mL Single Dose Vial | General Injectables & Vaccines, Inc | 20211113 |
| 91db3d26-b473-487b-88cb-dd79950ebddd | National Council for Prescription Drug Programs | 20120724 | |
| 626f861a-06bc-4df5-aba2-74614d1f7860 | National Council for Prescription Drug Programs | 20120724 | |
| 3a365cc7-1916-4972-b42c-6320b86cabd5 | National Council for Prescription Drug Programs | 20120724 | |
| b7b92d6e-11b4-4da9-9796-9c667b69fcb9 | National Council for Prescription Drug Programs | 20120724 | |
| b7f7b0dc-305d-4dc4-ba30-fe88b077d228 | National Council for Prescription Drug Programs | 20120724 | |
| 1383f5ee-8fac-417f-b30f-ad34be79a230 | National Council for Prescription Drug Programs | 20120724 | |
| 961C81A1-4DFC-4CFC-D8AA-94FE79F8B2D2 | Sensorcaine® (bupivacaine HCl Injection, USP) Sensorcaine®-MPF (bupivacaine HCl Injection, USP) Sensorcaine® with Epinephrine (bupivacaine HCl and epinephrine Injection, USP) 1:200,000 (as bitartrate) Sensorcaine®-MPF with Epinephrine (bupivacaine HCl and epinephrine Injection, USP) 1:200,000 (as bitartrate) | AstraZeneca LP | 20060705 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | epinephrine | |
| ATC | R03AA | Alpha- and beta-adrenoreceptor agonists | ATC1-4 | epinephrine | |
| ATC | N01BB | Amides | ATC1-4 | bupivacaine | |
| ATC | B02BC | Local hemostatics | ATC1-4 | epinephrine | |
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | epinephrine | |
| ATC | S01EA | Sympathomimetics in glaucoma therapy | ATC1-4 | epinephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | epinephrine | |
| FDASPL | D000577 | Amides | CHEM | has_chemical_structure | bupivacaine |
| FDASPL | D002395 | Catecholamines | CHEM | has_chemical_structure | epinephrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | bupivacaine |
| FDASPL | N0000175555 | beta-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175570 | Catecholamine | EPC | has_epc | epinephrine |
| FDASPL | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine |
| MEDRT | D002045 | Bupivacaine | CHEM | has_ingredient | bupivacaine hydrochloride |
| MEDRT | D004837 | Epinephrine | CHEM | has_ingredient | epinephrine |
| MEDRT | D000402 | Airway Obstruction | DISEASE | may_treat | epinephrine |
| MEDRT | D000707 | Anaphylaxis | DISEASE | may_treat | epinephrine |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | epinephrine |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | epinephrine |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bupivacaine hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | epinephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | epinephrine |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | epinephrine |
| MEDRT | D006327 | Heart Block | DISEASE | may_treat | epinephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | epinephrine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | bupivacaine |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | bupivacaine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | epinephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | epinephrine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | epinephrine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009921 | Adrenergic beta1-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | bupivacaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | bupivacaine |
| MEDRT | N0000008298 | Arterial Vasoconstriction | PE | has_pe | epinephrine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | epinephrine |
| MEDRT | N0000009944 | Decreased Intraocular Aqueous Secretion | PE | has_pe | epinephrine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | bupivacaine |
| MEDRT | N0000009014 | Decreased Uterine Smooth Muscle Contraction or Tone | PE | has_pe | epinephrine |
| MEDRT | N0000009070 | Hemostasis Alteration | PE | has_pe | epinephrine |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | has_pe | epinephrine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | bupivacaine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009809 | Positive Inotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | epinephrine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2.5 MG/ML / 0.005 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA070967 |
| CODES | ANDA | ANDA071165 |
| CODES | ANDA | ANDA071167 |
| CODES | SNOMEDCT | 408035004 |
| CODES | VUID | 4004274 |
| NAMES | Prescribable Synonym | BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution |
| NAMES | Tallman Synonym | BUPivacaine hydrochloride 0.25 % / EPINEPHrine (as EPINEPHrine bitartrate) 1:200,000 Injectable Solution |
| NAMES | Tallman Synonym | BUPivacaine hydrochloride 2.5 MG/ML / EPINEPHrine 0.005 MG/ML Injectable Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |